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REASONED OPINION 
Reasoned opinion on the modification of the existing MRL for spiromesifen 
in tea
1 
European Food Safety Authority
2,  
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
In accordance with Article 6 of Regulation (EC) No 396/2005, The United Kingdom, herewith referred to as the 
evaluating Member State (EMS), received an application from Bayer CropScience AG to set an import tolerance 
for the active substance spiromesifen in tea. In order to accommodate for the authorized uses of spiromesifen on 
tea in Japan, India and Indonesia, the EMS proposed to raise the existing MRL in tea to 50 mg/kg. The EMS 
drafted an evaluation report according to Article 8 of Regulation (EC) No 396/2005, which was submitted to the 
European Commission and forwarded to EFSA. According to EFSA, the data on black tea are sufficient to derive 
a MRL proposal of 50 mg/kg for the existing enforcement residue definition (spiromesifen) and 80 mg/kg for the 
residue definition proposed by the peer review (the sum of spiromesifen and spiromesifen-enol, expressed as 
spiromesifen). An adequate analytical enforcement method is available to control residues of spiromesifen and 
spiromesifen-enol in dry commodities. The applicant has to confirm that the method can be also used for the 
determination of spiromesifen residues in tea, which is considered as a matrix difficult to analyse. Based on the 
risk assessment results, EFSA concludes that the authorized use of spiromesifen on tea  will not result in a 
consumer exposure exceeding the toxicological reference values and therefore is unlikely to pose a public health 
risk. 
© European Food Safety Authority, 2012 
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SUMMARY 
In  accordance  with  Article  6  of  Regulation  (EC)  No  396/2005
3,  The United  Kingdom,  herewith 
referred to as the evaluating Member State (EMS),  received an application from Bayer CropScience 
AG to set an import tolerance for the active substance spiromesifen in tea.  In order to accommodate 
for the authorized uses of spiromesifen on tea in Japan, India and Indonesia, the EMS  proposed to 
raise the existing MRL in tea to 50 mg/kg. The EMS drafted an evaluation report according to Article 
8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded 
to EFSA on 18 April 2012.  
EFSA bases its assessment on the evaluation report submitted by the EMS, the Draft Assessment 
Report (DAR) prepared  by the rapporteur Member State (RMS) United Kingdom  under Council 
Directive 91/414/EEC
4 and the conclusion on the peer review of the pesticide risk assessment of the 
active substance spiromesifen.  
The toxicological profile of  spiromesifen was assessed in the framework of the peer review under 
Directive 91/414/EEC and the data were sufficient to  propose an ADI of 0.03 mg/kg bw per day and 
an ARfD of 2 mg/kg bw.  
The metabolism of  spiromesifen in primary crops was investigated in  fruit and fruiting vegetables, 
leafy vegetables and in oilseeds crop group. From these studies the  peer review concluded that the 
metabolism of spiromesifen was similar in all crop groups investigated. The residue definition for food 
of plant origin was proposed as spiromesifen and spiromesifen-enol (M01) expressed as spiromesifen, 
for both risk assessment and monitoring pu rposes. The existing enforcement residue definition 
established in Regulation (EC) No 396/2005 is set as spiromesifen only.  EFSA proposes that in the 
framework of Article 12 of Regulation (EC) No 396/2005  the existing residue definition is modified 
according to the conclusions derived by the peer review. For the uses on tea, EFSA concludes that the 
metabolism of spiromesifen is sufficiently addressed and the residue definitions agreed in the peer 
review are applicable. 
EFSA concludes that the submitted supervised residue trials on black tea  are sufficient to  derive a 
MRL proposal of 50 mg/kg for the existing enforcement residue definition   (spiromesifen)  and 
80 mg/kg for the residue definition proposed by the peer review   (the sum of spiromesifen and 
spiromesifen-enol,  expressed  as  spiromesifen) .  An  adequate  analytical  enforcement  method  is 
available to control residues of spiromesifen and spiromesifen-enol in dry commodities. The applicant 
has to confirm that the method can be also used for the determination of spiromesifen residues in tea, 
which is considered as a matrix difficult to analyse. 
Studies investigating the nature of  spiromesifen residues in processed commodities were assessed in 
the peer review  and  showed that the compound  was hydrolytically  not stable and was primarily 
degraded to spiromesifen-enol. The peer review proposed the same residue definition in processed 
commodities as in primary commodities. The effects of processing on the magnitude of spiromesifen 
residues during the production of tea were investigated as a part of residue trials. Due to the moisture 
loss, a residue  concentration in dried  tea was observed. A significant reduction of residues was 
observed in tea infusion.  
Since the proposed use of spiromesifen is on imported crops, investigations of residues in rotational 
crops are not required. Residues of spiromesifen in commodities of animal origin were not assessed in 
the framework of this application, since tea is not fed to livestock. 
The consumer risk assessment was performed with revision 2 of the EFSA Pesticides Residues Intake 
Model (PRIMo). For the calculation of the chronic exposure, EFSA used the median residue value as 
derived from the residue trials on black dried tea for the enforcement residue definition proposed by 
                                                       
3 Regulation (EC) No 396/2005 of the Parliament and of the Council of 23 February 2005. OJ L 70, 16.03.2005, p. 1-16. 
4 Council Directive 91/414/EEC of 15 July 1991. OJ L 230, 19.08.1991, p. 1-32. Modification of the existing MRL for spiromesifen in tea 
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the peer review. For the remaining commodities of plant and animal origin, the existing MRLs as 
established in Annex IIIA of Regulation (EC) No 396/2005 were used as input values. EFSA notes 
that these MRLs are established for the enforcement residue definition “spiromesifen” and no residue 
data  are  available  to  assess  the  contribution  of  spiromesifen-enol  residues  to  the  total  consumer 
exposure  from  the  existing  uses.  However,  since  in  the  exposure  calculation  the  MRLs  are  used 
instead of the risk assessment values, the calculation is considered to be conservative enough and is 
not likely to underestimate consumer risk. The acute exposure assessment was performed only with 
regard to black tea, assuming the consumption of a large portion of the food item as reported in the 
national food surveys containing residues at the median level as observed in supervised field trials.  
The  estimated  exposure  was  then  compared  with  the  toxicological  reference  values  derived  for 
spiromesifen. 
No long-term consumer intake concerns were identified for any of the European diets incorporated in 
the EFSA PRIMo. The total calculated intake values accounted for up to 19.9% of the ADI (WHO 
Cluster diet B). The contribution of residues in dried tea to the total consumer exposure accounted for 
a maximum of 9% of the ADI (IE adult diet). EFSA notes that the actual exposure via tea infusion 
would be significantly lower since the transfer rate from leaves to infusion is less than 100%. In 
addition, the margin of safety for the calculated exposure is considered sufficient to conclude that the 
possible  contribution  of  spiromesifen-enol  residues  from  the  existing  uses  to  the  total  consumer 
exposure would cause no consumer intake concerns. 
No acute consumer risk was identified in relation to the residues of spiromesifen in tea. The calculated 
maximum exposure from tea in percentage of the ARfD was 0.9%. 
EFSA concludes that the authorized use of spiromesifen on tea will not result in a consumer exposure 
exceeding the toxicological reference values and therefore is unlikely to pose a public health risk.  
Thus EFSA proposes to amend the existing MRLs as reported in the summary table. 
Summary table 
Code 
number
(a) 
Commodity  Existing 
EU MRL 
(mg/kg) 
Proposed 
EU MRL 
(mg/kg) 
Justification for the proposal 
Enforcement residue definition: Spiromesifen 
0610000  Tea (dried leaves and 
stalks,  fermented  or 
otherwise of Camellia 
sinensis) 
0.02*
  50
  The  MRL  proposal  is  sufficiently 
supported  by  data  and  no  risk  for 
consumers was identified. 
(a):  According to Annex I of Regulation (EC) No 396/2005. 
(*):  Indicates that the MRL is set at the limit of analytical quantification. Modification of the existing MRL for spiromesifen in tea 
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BACKGROUND 
Regulation  (EC)  No  396/2005  establishes  the  rules  governing  the  setting  of  pesticide  MRLs  at 
European Union level. Article 6 of that Regulation lays down that any party having a legitimate 
interest or requesting an authorisation for the use of a plant protection product in accordance with 
Council Directive 91/414/EEC, repealed by Regulation (EC) No 1107/2009, shall submit to a Member 
State, when appropriate, an application to set or to modify an MRL in accordance with the provisions 
of Article 7 of that Regulation. 
The United Kingdom, hereafter referred to as the evaluating Member State (EMS), received from the 
company Bayer CropScience AG
5 an application to set an import tolerance for the active sub stance 
spiromesifen  in  tea. This application was notified to the European Commission and EFSA and 
subsequently evaluated by the EMS in accordance with Article 8 of the Regulation. After completion, 
the evaluation report was submitted to the European Commission who forwarded the application, the 
evaluation report and the supporting dossier to EFSA on 18 April 2012.  
The application was included in the EFSA Register of Questions with the reference number EFSA-Q-
2012-00504 and the following subject: 
Spiromesifen – Application to modify the existing MRL in tea. 
The EMS proposed to raise the existing MRL of spiromesifen in tea from the limit of quantification at 
0.02 mg/kg to 50 mg/kg. 
EFSA  proceeded  with the  assessment of  the  application  and the  evaluation report  as required  by 
Article 10 of the Regulation. 
TERMS OF REFERENCE 
In accordance with Article 10 of Regulation (EC) No 396/2005, EFSA shall, based on the evaluation 
report  provided  by  the  evaluating  Member  State,  provide  a  reasoned  opinion  on  the  risks  to  the 
consumer associated with the application. 
In accordance with Article 11 of that Regulation, the reasoned opinion shall be provided as soon as 
possible and at the latest within three months (which may be extended to six months where more 
detailed evaluations need to be carried out) from the date of receipt of the application. Where EFSA 
requests supplementary information, the time limit laid down shall be suspended until that information 
has been provided. 
In this particular case the calculated deadline for providing the reasoned opinion is 18 July 2012. 
 
                                                       
5 Bayer CropScience AG, Global Regulatory Affairs, Alfred-Nobel-Strasse 50, D51368, Leverkusen, Germany Modification of the existing MRL for spiromesifen in tea 
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THE ACTIVE SUBSTANCE AND ITS USE PATTERN 
Spiromesifen  is  the  ISO  common  name  for  3-mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-yl  3,3-
dimethylbutyrate (IUPAC). The chemical structure of the compound is herewith reported. 
 
Molecular weight: 370.49  
Spiromesifen  is  a  non-systemic  insecticide/acaricide  belonging  to  the  chemical  class  of  cyclic 
ketoenoles. Spiromesifen is an acetyl CoA carboxylase inhibitor. The biological activity of cyclic 
ketoenoles correlates with inhibition of lipogenesis, resulting in decreased lipid contents, especially of 
triglycerides and free fatty acids, in treated insects (The United Kingdom, 2004). 
Spiromesifen  is  a  new  active  substance  currently  not  yet  approved  under  Regulation  (EC)  No 
1107/2009
6. The United Kingdom is acting as a rapporteur Member State (RMS). The peer review of 
spiromesifen according to  Commission  Regulation (EU) No 188/2011
7  is finalized and an EFSA 
conclusion is issued (EFSA, 2012). The representative uses evaluated by the peer review were foliar 
application on various vegetables in permanent greenhouses.  
The EU MRLs for  spiromesifen  are established in Annex   IIIA  of Regulation (EC) No 396/2005 
(Appendix C). The existing EU MRL for spiromesifen in tea is set  at the LOQ of 0.02 mg/kg. No 
CXLs are established for spiromesifen. 
The details of the authorised GAPs for spiromesifen on tea plants in Indonesia, Japan (critical GAP) 
and India, which would require setting of an import tolerance in tea, are given in Appendix A. 
   
                                                       
6 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009, OJ L 309, 24.11.2009, 
p.1-50 
7 Commission Regulation (EU) No 188/2011 of 25 February 2011. OJ L 53, 26.02.2011, p. 51-55. Modification of the existing MRL for spiromesifen in tea 
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ASSESSMENT 
EFSA bases its assessment on the evaluation report submitted by the EMS (The United Kingdom, 
2012),  the  Draft  Assessment  Report  (DAR)  and  its  addendum  prepared  under  Council  Directive 
91/414/EEC
8  (The  United Kingdom, 2004, 2009)  and  the conclusions  on the peer review of the 
pesticide risk assessment of the active substance  spiromesifen  (EFSA, 2012).  The assessment is 
performed in accordance with the legal provisions of the Uniform Principles for the Evaluation and the 
Authorisation of Plant Protection Products adopted by Commission Regulation (EU) No 546/2011
9 
and the currently applicable guidance documents relevant for the consumer risk assessment of 
pesticide residues (EC, 1996, 1997a, 1997b, 1997c, 1997d, 1997e, 1997f, 1997g, 2000, 2010a, 2010b, 
2011; OECD, 2011). 
1.  Method of analysis 
1.1.  Methods for enforcement of residues in food of plant origin 
Analytical methods for the determination of spiromesifen residues in plant commodities were assessed 
in the DAR and during the peer review under Directive 91/414/EEC (The United Kingdom, 2004, 
2009; EFSA, 2012). 
The HPLC-MS/MS method is considered sufficiently validated for the determination of spiromesifen 
and its metabolite spiromesifen-enol in plant matrices with high acid-, high water-, high oil content 
and in dry matrices at an individually validated LOQ of 0.01 mg/kg (EFSA, 2012). The combined 
LOQ for the proposed residue definition (sum of spiromesifen and spiromesifen-enol, expressed as 
spiromesifen) is 0.02 mg/kg. The EMS is of the opinion that the above mentioned analytical method 
can be used for the determination of spiromesifen and spiromesifen-enol residues in dried tea.  
Since tea is considered as a commodity difficult to analyse, EFSA concludes that the applicability of 
the  HPLC-MS/MS  method  for  the  determination  of  spiromesifen  residues  in  dried  tea  has  to  be 
confirmed by providing validation data for the crop under consideration.  
1.2.  Methods for enforcement of residues in food of animal origin 
Analytical methods for the determination of residues in food of animal origin were not assessed in the 
current application, since tea is not fed to livestock.  
2.  Mammalian toxicology 
The toxicological profile of the active substance spiromesifen was assessed in the framework of the 
peer review under Directive 91/414/EEC (The United Kingdom, 2004; EFSA, 2012). The data were 
sufficient to derive toxicological reference values for spiromesifen which are compiled in Table 2-1. 
Table 2-1:  Overview of the toxicological reference values 
  Source  Year  Value  Study relied upon  Safety 
factor 
Spiromesifen 
ADI  EFSA  2012  0.03 mg/kg bw per day  90 day and 18 month 
mouse studies 
100 
ARfD  EFSA  2012  2 mg/kg bw  Acute neurotoxicity 
study 
100 
                                                       
8 Council Directive 91/414/EEC of 15 July 1991. OJ L 230, 19.08.1991, p. 1-32. 
9 Commission Regulation (EU) No 546/2011 of 10 June 2011. OJ L 155, 11.06.2011, p. 127-175. Modification of the existing MRL for spiromesifen in tea 
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3.  Residues 
3.1.  Nature and magnitude of residues in plant  
3.1.1.  Primary crops  
3.1.1.1.  Nature of residues  
The metabolism of spiromesifen in primary crops was evaluated by the RMS United Kingdom (The 
United Kingdom, 2004) and reviewed by EFSA (EFSA, 2012) in the framework of the peer review 
under  Directive  91/414/EEC.  Metabolism  studies  using  dihydrofuranone-3-
14C  spiromesifen  have 
been performed with tomatoes, lettuce and cotton and the overview of the study designs is presented in 
the table below. 
Table 3-1:  Summary of available metabolism studies in plants 
Group  Crop  Label 
position 
Application details 
Method,  
F or G
(a) 
Rate  
(kg a.s./ha) 
No/ 
Interval 
Sampling 
(DAT) 
Remarks 
Fruits and 
fruiting 
vegetable 
Tomatoes  Dihydrofu-
ranone-3-
14C 
G  0.44+0.38  2/24 days  7 
(maturity) 
Leaves, 
fruits 
sampled 
Leafy 
vegetables  
Lettuce  G  0.3  2/42 days  7   
0.225  
(4 plants) 
0.347  
(4 plants) 
Pulses and 
oilseeds 
Cotton  G  0.3   3 /7 days  21   Gin trash, 
cotton bolls 
(lint and 
undelinted 
seed) 
sampled 
1  1 
(a):  Outdoor/field use (F) or glasshouse/protected crops/indoor application (G) 
 
Spiromesifen was the main component of the residue in mature tomato fruits (86% of the TRR), in 
lettuce (58% TRR), and in cotton seed and gin trash (17% and 26% TRR). Metabolites observed were, 
amongst others, spiromesifen-enol (M01)
10 (below 3% TRR in tomato and lettuce and up to 50% TRR 
in cotton commodities), spiromesifen-4-hydroxymethyl (M02)
11 and its glucoside (M03)
12 (sum ca. 
7% TRR in tomato and cotton, 16% in lettuce). A major metabolite in lettuce was also dihydroxy- 
spiromesifen-enol (M04)
13 (6% TRR). All other components were present in insignificant amounts  
(EFSA, 2012).  
 
The peer review concluded that the metabolism of spiromesifen was similar in all crop groups 
investigated. The residue definition for food of plant origin was proposed as   spiromesifen and 
spiromesifen-enol (M01) expressed as spiromesifen for both  the  risk assessment and monitoring 
purposes (EFSA, 2012). The existing enforcement residue definition established in Regulation (EC) 
No 396/2005 is set as spiromesifen only. EFSA  proposes that it is modified according to the 
                                                       
10spiromesifen-enol (M01): See Appendix D 
11 spiromesifen-4-hydroxymethyl (M02) See Appendix D 
12 glucoside of spiromesifen-4-hydroxymethyl (M03): See Appendix D 
13 dihydroxy spiromesifen enol (M04): See Appendix D Modification of the existing MRL for spiromesifen in tea 
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conclusions of the peer review. However, since this will have an impact on the existing MRLs, the 
amendment of the enforcement residue definition should be implemented only in the framework of the 
MRL review according to Article 12 of Regulation (EC) No 396/2005.  
For the uses on tea, EFSA concludes that the metabolism of spiromesifen is sufficiently addressed and 
the residue definitions agreed in the peer review are applicable.  
3.1.1.2.  Magnitude of residues 
The applicant submitted 10 GAP compliant residue trials on tea. Residue trials have been performed in 
Japan and India in 2004 and 2008. In 2 residue trials samples of tea infusion were analysed and in one 
residue trial samples of green tea, black tea, black tea infusion and instant tea were analysed; these 
data were used to assess the effect of processing/drying on the magnitude of residues (see section 
3.1.1.3.). Four residue trials provide data on residues in crude tea (green tea) whereas the remaining 6 
residue trials provide information on residues in fresh tea leaves.  
All  trial  samples  were  analysed  for  spiromesifen  and  spiromesifen-enol.  Two  residue  trials  were 
analysed also for metabolites M02 and M03, but these data were not considered by EFSA. The LOQ 
for dried tea was 0.05 mg/kg for spiromesifen and 0.03-0.04 mg/kg for spiromesifen-enol. The LOQ 
for each compound in fresh leaves was 0.01 mg/kg. The applicant and the EMS had reported the 
residue data as the sum of spiromesifen and spiromesifen-enol without applying a molecular weight 
conversion factor of 1.36
14. EFSA recalculated the submitted data accordingly and that  led to higher 
values than calculated by the EMS. 
Considering that the peer review proposed the modification of the enforcement residue definition, 
EFSA derived two MRL proposals, which reflect the existing residue definition (spiromesifen) and the 
residue definition proposed by the peer review (the sum o f spiromesifen and spiromesifen -enol, 
expressed as spiromesifen). The residues in fresh tea leaves were recalculated to a dried green tea and 
dried black tea by applying the respective drying factors as derived in section 3.1.1.3. Residue data on 
crude tea  were combined with residue data  on  dried  green tea.  Residue data indicate that higher 
residues are expected in black tea and thus the MRL proposal and risk assessment values were based 
on this data set. Tea is a major crop in the world according to EU gui dance document and at least 8 
residue trials would be required (EC, 2011). It is noted that a full data set has been provided only for 
green tea. However, the lack of two trials on black tea was considered as a minor data gap, taking into 
account that a full data package is available for green tea. Additional trials on black tea are therefore 
not required. Based on the residue data on black tea, a MRL proposal of 50 mg/kg is derived for the 
existing residue definition and a MRL proposal of 80 mg/kg is deriv ed for the enforcement residue 
definition derived by the peer review. 
The results of the residue trials, the related risk assessment input values (highes t residue, median 
residue) and the MRL proposal are summarised in Table 3-2.  
The storage stability of  spiromesifen and its metabolite M01  in  high water content matrices   was 
investigated in the DAR under Directive 91/414/EEC (The United Kingdom 2004; EFSA, 2012). The 
total residues have been found to be stable for up to 2 years in high water content  matrices under 
frozen conditions. Spiromesifen  was stable only for 6 months in French bean and  during longer 
storage intervals converts to spiromesifen-enol (EFSA, 2012). Fresh tea leaf samples (6 trials) prior to 
analysis were stored for 7 months -20º C, indicating that residue data are valid with regard to storage 
stability. Crude tea (dried tea) samples were stored at ambient temperature for 20  days (one sample) 
and 40 days (one sample) or stored frozen for 3-8 days prior to analysis (2 samples). There is no study 
available investigating the stability of spiromesifen residues in dry commodities and such studies are 
not required as all trial samples (except one) were analysed within 30 days from sampling (EC, 1997f). 
The stability of total residues in watery matrices is demonstrated for 2 years of storage and thus  it is 
                                                       
14 MW spiromesifen 370.49 /MW spiromesifen-enol (272.34) Modification of the existing MRL for spiromesifen in tea 
 
EFSA Journal 2012;10(12):3050  10 
unlikely that in dry matrix a faster degradation had occurred during the storage interval of 40 days. 
Thus, it is concluded that the residue data are valid with regard to storage stability.  
According to the EMS, the analytical methods used to analyse the supervised residue trial samples 
have been sufficiently validated and were proven to be fit for purpose (The United Kingdom, 2012).   Modification of the existing MRL for spiromesifen in tea 
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Table 3-2:  Overview of the available residues trials data  
Commodity  Residue 
region 
(a) 
Outdoor/ 
Indoor 
Individual trial results (mg/kg)  Median 
residue  
(mg/kg) 
(b) 
Highest 
residue 
(mg/kg) 
(c) 
MRL 
proposal 
(mg/kg)
  
Median 
CF  
(d) 
Comments
 
(e) 
 
Enforcement  
 
Risk assessment  
Existing enforcement residue definition: spiromesifen 
Proposed risk assessment residue definition: spiromesifen and spiromesifen-enol (M01) expressed as spiromesifen)  (EFSA, 2012) 
Tea  
(dried 
leaves) 
Import  
(Japan, 
India) 
Outdoor  Crude  tea:  14.75;  2.84; 
13.6; 2.73 
 
Green tea: 14.33
f; 15.35
f; 
2.64
f; 1.14
f; 17.37
f; 8.36
f 
Crude  tea:  20.97;  6.36; 
24.3; 7.71 
 
Green  tea:  17.41
h; 
19.10
h;  3.63
h;  1.71
h; 
25.71
h; 10.87
h 
10.98  17.37  35 or  40  1.45  Rber= 29.8 
Rmax= 28.02 
MRLOECD = 35.03/40 
Black tea: 17.36
g; 18.6
g; 
3.2
g;  1.39
g;  21.04
g; 
10.13
g 
Black tea: 25.11
i; 27.56
i; 
5.24
i;  2.46
i;  37.09
i; 
15.68
i 
 13.75   21.04  50  1.59   Rber= 38.42 
Rmax= 42.89 
MRLOECD =45.3/50 
 
Proposed enforcement residue definition: spiromesifen and spiromesifen-enol (M01) expressed as spiromesifen (EFSA, 2012) 
Proposed risk assessment residue definition: spiromesifen and spiromesifen-enol (M01) expressed as spiromesifen  (EFSA, 2012) 
Tea  
(dried 
leaves) 
Import  
(Japan, 
India) 
Outdoor  Crude  tea:  20.97;  6.36; 
24.3; 7.71  
 
Green  tea:  17.41
h; 
19.10
h;  3.63
h;  1.71
h; 
25.71
h; 10.87
h 
Crude  tea:  20.97;  6.36; 
24.3; 7.71 
 
Green  tea:  17.41
h; 
19.10
h;  3.63
h;  1.71
h; 
25.71
h; 10.87
h 
14.14  25.71  50  1  Rber= 43.61 
Rmax= 39.36 
MRLOECD = 48.93/50 
Black tea:  
25.11
i;  27.56
i;  5.24
i; 
2.46
i; 37.09
i; 15.68
i 
Black tea:  
25.11
i;  27.56
i;  5.24
i; 
2.46
i; 37.09
i; 15.68
i 
20.40  37.09  80  1  Rber= 59.89 
Rmax= 68.97 
MRLOECD =72.87/80.00 
(a):  NEU (Northern and Central Europe), SEU (Southern Europe and Mediterranean), EU (i.e. outdoor use) or Import (country code) (EC, 2011).  
(b):  Median value of the individual trial results according to the enforcement residue definition. 
( c): Highest value of the individual trial results according to the enforcement residue definition. 
(d):  The median conversion factor for enforcement to risk assessment is obtained by calculating the median of the individual conversion factors for each residue trial. Modification of the existing MRL for spiromesifen in tea 
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(e):  Statistical estimation of MRLs according to the EU methodology (Rber, Rmax; EC, 1997g) and unrounded/rounded values according to the OECD methodology (OECD, 2011). 
(f):  Residue data on fresh leaves (6.89; 7.38; 1.27; 0.55; 8.35; 4.02) recalculated to dried green tea, by applying the drying factor of 2.08 as derived for dried green tea for spiromesifen (see 
3.1.1.3.) 
(g):  Residue data on fresh leaves (6.89; 7.38; 1.27; 0.55; 8.35; 4.02) recalculated to dried black tea, by applying the drying factor of 2.52 as derived for dried black tea for spiromesifen (see 
3.1.1.3.) 
(h):  Residue data on fresh leaves (7.13; 7.83; 1.49; 0.7; 10.54; 4.45) recalculated to dried green tea, by applying the drying factor of 2.44 as derived for dried green tea (see 3.1.1.3.) 
(i):   Residue data on fresh leaves (7.13; 7.83; 1.49; 0.7; 10.54; 4.45) recalculated to dried black tea, by applying the drying factor of 3.52 as derived for dried black tea (see 3.1.1.3.) 
 Modification of the existing MRL for spiromesifen in tea 
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3.1.1.3.  Effect of industrial processing and/or household preparation 
The effect of processing on the nature of spiromesifen was investigated in studies performed at three 
test  conditions  representing  pasteurisation,  baking/brewing/boiling  and  sterilisation  (20  minutes  at 
90 C, pH 4; 60 minutes at 100 C pH 5; 20 minutes at 120 C, pH 6) (The United Kingdom, 2004).  
The results of the hydrolysis study demonstrated that spiromesifen was hydrolytically not stable and 
was primarily degraded to spiromesifen-enol (M01) which accounted for up to 89% of the terminal 
residues after sterilisation, up to 83.5% after baking/boiling and up to 21% after pasteurisation. Other 
degradation products were not significant (EFSA, 2012). The peer review proposed the same residue 
definition in processed commodities as in primary commodities. 
The effects of processing on the magnitude of spiromesifen residues during the production of tea were 
investigated as a part of residue trials. Three residue trials provide data on residues in tea infusion (two 
trials on green tea infusion and one trial on black tea infusion) and one residue trial provides data on 
residues in dried green tea, dried black tea and instant tea. From the latter trial drying factors for green 
and black tea were derived (Table 3-3). No details were provided on processing conditions.  
Higher residues compared to the unprocessed commodity were observed in dried black tea than in 
dried green tea; this accumulation is due to the loss of moisture. Significant reduction of residues 
occurs in tea infusions (2% of residues were transferred from black tea into the black tea infusion and 
ca. 50% of residues were transferred from green tea into the green tea infusion), however, the amount 
of tea used to prepare a tea infusion was not reported and therefore adequate transfer factors could not 
be derived. Drying factors were derived for the existing enforcement residue definition (spiromesifen) 
and the residue definition proposed by the peer review (the sum of spiromesifen and spiromesifen-
enol, expressed as spiromesifen). 
Table 3-3:  Overview of the available processing studies 
Processed commodity  Number 
of studies 
Median 
PF 
(a) 
Median 
CF 
(b) 
Comments 
Enforcement residue definition: spiromesifen 
Tea leaves, green tea  1  2.08  1.17   
Tea leaves, black tea  1  2.52  1.4   
Proposed enforcement residue definition: spiromesifen and spiromesifen-enol (M01) expressed as 
spiromesifen 
Tea leaves, green tea  1  2.44  1   
Tea leaves, black tea  1  3.52  1   
(a):  The  median  processing  factor  is  obtained  by  calculating  the  median  of  the  individual  processing  factors  of  each 
processing study. 
(b): The median conversion factor for enforcement to risk assessment is obtained by calculating the median of the individual 
conversion factors of each processing study. 
The derived drying factors are not recommended to be included in Annex VI of Regulation (EC) No 
396/2005 since the MRL is already set for a processed commodity, i.e., dried tea. 
3.1.2.  Rotational crops 
The  residues  of  spiromesifen  in  rotational  crops  are  of  no  relevance  for  the  import  tolerance 
application. Modification of the existing MRL for spiromesifen in tea 
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3.2.  Nature and magnitude of residues in livestock 
Since  tea  is  not  normally  fed  to  livestock,  the  nature  and  magnitude  of  spiromesifen  residues  in 
livestock is not assessed in the framework of this application (EC, 1996).  
4.  Consumer risk assessment 
The consumer risk assessment was performed with revision 2 of the EFSA Pesticide Residues Intake 
Model (PRIMo). This exposure assessment model contains the relevant European food consumption 
data for different sub-groups of the EU population
15 (EFSA, 2007).  
For the calculation of the chronic exposure, EFSA used the median residue value as derived from the 
residue trials on black dried tea (see Table 3-2). For the remaining commodities of plant and animal 
origin, the existing MRLs as established in Annex IIIA of Regulation (EC) No 396/2005 were used as 
input values. EFSA notes that the existing MRLs are established for the enforcement residue definition 
“spiromesifen”  and  no  residue  data  are  available  to  assess  the  contribution  of  spiromesifen-enol 
residues to the total chronic consumer exposure from the existing uses. Thus, this lack of information 
is leading to an increased level of uncertainty. However, since in the exposure calculation the MRLs 
are used instead of the risk assessment values, the calculation is considered to be conservative enough 
and is not likely to underestimate consumer risk. 
The  model  assumptions  for  the  long-term  exposure  assessment  are  considered  to  be  sufficiently 
conservative for a first tier exposure assessment, assuming that all food items consumed have been 
treated with the active substance under consideration. In reality, it is not likely that all food consumed 
will contain residues at the MRL or at levels of the median residue values identified in supervised field 
trials. However, if this first tier exposure assessment does not exceed the toxicological reference value 
for long-term exposure (i.e. the ADI), a consumer health risk can be excluded with a high probability.  
The  acute  exposure  assessment  was  performed  only  with  regard  to  black  tea,  assuming  the 
consumption of a large portion of the food item as reported in the national food surveys containing 
residues at the median level as observed in supervised field trials. A variability factor accounting for 
the inhomogeneous distribution on the individual items consumed was included in the calculation, 
when required (EFSA, 2007). 
The input values used for the dietary exposure calculation are summarised in Table 4-1. 
Table 4-1:  Input values for the consumer dietary exposure assessment 
Commodity  Chronic exposure assessment  Acute exposure assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Risk assessment residue definition: spiromesifen and spiromesifen-enol (M01) expressed as spiromesifen 
Black (dried) tea  20.40  Median residue  
(Table 3-2) 
20.40  Median residue  
(Table 3-2) 
Existing risk  assessment residue definition: spiromesifen  
Other  commodities  of 
plant and animal origin 
MRL
 a  See Appendix C  Acute risk assessment was undertaken 
only with regard to the crop under 
consideration. 
(a): The existing MRLs are established for the enforcement residue definition “spiromesifen”. The EU MRLs above the LOQ 
are set for strawberries, passion fruit, papaya, fruiting vegetables, beans (with pods) and cucurbits. 
                                                       
15 The calculation of the long-term exposure (chronic exposure) is based on the mean consumption data representative for 22 
national diets collected from MS surveys plus 1 regional and 4 cluster diets from the WHO GEMS Food database; for the 
acute exposure assessment the most critical large portion consumption data from 19 national diets collected from MS surveys 
is used. The complete list of diets incorporated in EFSA PRIMo is given in its reference section (EFSA, 2007). Modification of the existing MRL for spiromesifen in tea 
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The  estimated  exposure  was  then  compared  with  the  toxicological  reference  values  derived  for 
spiromesifen (see Table 2-1). The results of the intake calculation are presented in Appendix B to this 
reasoned opinion.  
No long-term consumer intake concerns were identified for any of the European diets incorporated in 
the EFSA PRIMo. The total calculated intake values accounted for up to 19.9% of the ADI (WHO 
Cluster diet B). The contribution of residues in dried tea to the total consumer exposure accounted for 
a maximum of 9% of the ADI (IE adult diet). EFSA notes that the actual exposure via tea infusion 
would be significantly lower since the transfer rate from leaves to infusion is less than 100%. In 
addition, the margin of safety for the calculated exposure is considered sufficient to conclude that the 
possible  contribution  of  spiromesifen-enol  residues  from  the  existing  uses  to  the  total  consumer 
exposure would cause no consumer intake concerns. 
No acute consumer risk was identified in relation to the residues of spiromesifen in tea. The calculated 
maximum exposure from tea in percentage of the ARfD was 0.9%. 
Since no consumer intake concerns were identified with regard to the combined spiromesifen and 
spiromesifen-enol residues in tea with a resulting MRL proposal of 80 mg/kg, it is concluded that no 
consumer intake concerns are associated with the residues of spiromesifen in tea with a resulting lower 
MRL proposal of 50 mg/kg.  
EFSA concludes that the authorized use of spiromesifen on tea will not result in a consumer exposure 
exceeding the toxicological reference values and therefore is unlikely to pose a public health concern. 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
The toxicological profile of spiromesifen was assessed in the framework of the peer review under 
Directive 91/414/EEC and the data were sufficient to propose an ADI of 0.03 mg/kg bw per day and 
an ARfD of 2 mg/kg bw.  
The metabolism of spiromesifen in primary crops was investigated in fruit and fruiting vegetables, 
leafy vegetables and in oilseeds crop group. From these studies the peer review concluded that the 
metabolism of spiromesifen was similar in all crop groups investigated. The residue definition for food 
of plant origin was proposed as spiromesifen and spiromesifen-enol (M01) expressed as spiromesifen, 
for  both  risk  assessment  and  monitoring  purposes.  The  existing  enforcement  residue  definition 
established in Regulation (EC) No 396/2005 is set as spiromesifen only. EFSA proposes that in the 
framework of Article 12 of Regulation (EC) No 396/2005 the existing residue definition is modified 
according to the conclusions derived by the peer review. For the uses on tea, EFSA concludes that the 
metabolism of spiromesifen is sufficiently addressed and the residue definitions agreed in the peer 
review are applicable. 
EFSA concludes that the submitted supervised residue trials data on black tea are sufficient to derive a 
MRL  proposal  of  50  mg/kg  for  the  existing  enforcement  residue  definition  (spiromesifen)  and 
80 mg/kg  for  the  residue  definition  proposed  by  the  peer  review  (the  sum  of  spiromesifen  and 
spiromesifen-enol, expressed as spiromesifen). Adequate analytical enforcement method is available 
to control residues of spiromesifen and spiromesifen-enol in dry commodities at the combined LOQ of 
0.02 mg/kg. The applicant has to confirm that the method is able to analyse residues also in tea, which 
is considered as a matrix difficult to analyse. 
Studies investigating the nature of spiromesifen residues in processed commodities were assessed in 
the  peer  review  and  showed  that  the  compound  was  hydrolytically  unstable  and  was  primarily 
degraded to spiromesifen-enol. The peer review proposed the same residue definition in processed 
commodities as in primary commodities. The effects of processing on the magnitude of spiromesifen 
residues during the production of tea were investigated as a part of residue trials. Due to the moisture 
loss,  a  residue  concentration  in  dried  tea  was  observed.  A  significant  reduction  of  residues  was 
observed in tea infusion.  
Since the proposed use of spiromesifen is on imported crops, investigations of residues in rotational 
crops are not required. Residues of spiromesifen in commodities of animal origin were not assessed in 
the framework of this application, since the tea is not fed to livestock. 
The consumer risk assessment was performed with revision 2 of the EFSA Pesticides Residues Intake 
Model (PRIMo). For the calculation of the chronic exposure, EFSA used the median residue value as 
derived from the residue trials on black dried tea for the enforcement residue definition proposed by 
the peer review. For the remaining commodities of plant and animal origin, the existing MRLs as 
established in Annex IIIA of Regulation (EC) No 396/2005 were used as input values. EFSA notes 
that these MRLs are established for the enforcement residue definition “spiromesifen” and no residue 
data are available to assess the contribution of spiromesifen-enol residues the total consumer exposure 
from the existing uses. However, since in the exposure calculation the MRLs are used instead of the 
risk assessment values, the calculation is considered to be conservative enough and is not likely to 
underestimate consumer risk. The acute exposure assessment was performed only with regard to black 
tea, assuming the consumption of a large portion of the food item as reported in the national food 
surveys containing residues at the median level as observed in supervised field trials.  
The  estimated  exposure  was  then  compared  with  the  toxicological  reference  values  derived  for 
spiromesifen. Modification of the existing MRL for spiromesifen in tea 
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No long-term consumer intake concerns were identified for any of the European diets incorporated in 
the EFSA PRIMo. The total calculated intake values accounted for up to 19.9% of the ADI (WHO 
Cluster diet B). The contribution of residues in dried tea to the total consumer exposure accounted for 
a maximum of 9% of the ADI (IE adult diet). EFSA notes that the actual exposure via tea infusion 
would be significantly lower since the transfer rate from leaves to infusion is less than 100%. In 
addition, the margin of safety for the calculated exposure is considered sufficient to conclude that the 
possible  contribution  of  spiromesifen-enol  residues  from  the  existing  uses  to  the  total  consumer 
exposure would cause no consumer intake concerns. 
No acute consumer risk was identified in relation to the residues of spiromesifen in tea. The calculated 
maximum exposure from tea in percentage of the ARfD was 0.9%. 
EFSA concludes that the authorized use of spiromesifen on tea will not result in a consumer exposure 
exceeding the toxicological reference values and therefore is unlikely to pose a public health risk. 
RECOMMENDATIONS 
Code 
number
(a) 
Commodity  Existing 
EU MRL 
(mg/kg) 
Proposed 
EU MRL 
(mg/kg) 
Justification for the proposal 
Enforcement residue definition: Spiromesifen 
0610000  Tea (dried leaves and 
stalks,  fermented  or 
otherwise of Camellia 
sinensis) 
0.02*
  50
  The  MRL  proposal  is  sufficiently 
supported  by  data  and  no  risk  for 
consumers was identified. 
(a):  According to Annex I of Regulation (EC) No 396/2005. 
(*):  Indicates that the MRL is set at the limit of analytical quantification. 
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APPENDICES 
A.  GOOD AGRICULTURAL PRACTICE (GAPS) 
Crop 
and/or 
situation 
 
 
(a) 
Member State 
or Country  
F 
G 
or 
I 
(b) 
Pest or 
group of pests 
controlled 
 
© 
Formulation  Application  Application rate per treatment  PHI 
(days) 
 
 
(l) 
Remarks 
 
 
 
(m) 
type 
 
 
(d – f) 
conc. 
Of a.s. 
 
(i) 
method 
kind 
 
(f – h) 
growth 
stage & 
season 
(j) 
number 
min max 
 
(k) 
interval 
min max 
kg as/hL 
min max 
water 
L/ha 
min max 
kg 
a.s./ha 
min max 
Tea  INDIA  F  Spider 
mites/Insects  SC  240 g/L  Spray  At 
infestation  1  -      0.096  7   
Tea  JAPAN  F  Spider 
mites/Insects  SC  316.5 g/L  Spray  At 
infestation  1  -      0.6  7  Critical GAP 
Tea  INDONESIA  F  Spider 
mites/Insects  SC  240    At 
infestation  3  -      0.144  15   
Remarks:  (a) 
 
(b) 
© 
(d) 
(e) 
 
(f) 
(g) 
For crops, EU or other classifications, e.g. Codex, should be used; where 
relevant, the use situation should be described (e.g. fumigation of a structure)  
Outdoor or field use (F), glasshouse application (G) or indoor application (I) 
e.g. biting and sucking insects, soil born insects, foliar fungi, weeds 
e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR) 
GCPF Technical Monograph No 2, 4
th Ed., 1999 or other codes, e.g. 
OECD/CIPAC, should be used 
All abbreviations used must be explained 
Method, e.g. high volume spraying, low volume spraying, spreading, dusting, 
drench 
(h) 
 
(i) 
(j) 
 
 
(k) 
 
(l) 
(m) 
Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between the plants – type 
of equipment used must be indicated 
g/kg or g/l 
Growth stage at last treatment (Growth stages of mono-and dicotyledonous plants. BBCH 
Monograph, 2
nd Ed., 2001), including where relevant, information on season at time of 
application 
The minimum and maximum number of application possible under practical conditions of use 
must be provided 
PHI – minimum pre-harvest interval 
Remarks may include: Extent of use/economic importance/restrictions (i.e. feeding, grazing) 
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B.  PESTICIDE RESIDUES INTAKE MODEL (PRIMO ) 
 
Status of the active substance: Pending Code no.
LOQ (mg/kg bw): 0.02 proposed LOQ:
ADI (mg/kg bw/day): 0.03 ARfD (mg/kg bw): 2
Source of ADI: EFSA Source of ARfD: EFSA
Year of evaluation: 2012 Year of evaluation: 2012
Chronic risk assessment - refined calculations
4 20
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
19.9 WHO Cluster diet B  10.3 2.7 1.1 Beans (with pods) 2.4
16.3 IE adult 9.0 1.3 0.8 Strawberries  2.1
11.7 FR toddler 3.7 2.6 2.1 Strawberries  2.9
10.4 DE child 3.2 1.6 0.8 Apples 2.8
9.8 NL child 2.1 1.7 1.4 Tea (dried leaves and stalks,  3.2
9.7 WHO regional European diet  3.7 2.6 0.7 Beans (with pods) 1.3
9.2 UK Infant  3.9 1.3 1.2 Tomatoes 3.1
9.0 WHO cluster diet D 3.4 2.4 0.4 Wheat 1.5
8.3 UK Toddler 2.0 1.9 1.5 Sugar beet (root) 3.4
7.6 FR infant 2.8 1.6 0.9 Milk and cream,  1.9
7.5 WHO cluster diet E 2.3 1.8 0.9 Beans (with pods) 1.6
7.3 UK vegetarian 3.4 2.1 0.3 Sugar beet (root) 1.0
7.1 IT kids/toddler 4.8 0.4 0.4 Strawberries  0.9
6.6 ES child 3.3 0.8 0.4 Milk and cream,  1.6
6.5 UK Adult  3.7 1.5 0.3 Sugar beet (root) 0.9
6.4 DK child 1.8 1.6 0.4 Milk and cream,  1.9
6.4 SE  general population 90th percentile 2.6 0.6 0.4 Milk and cream,  1.6
6.0 IT adult 3.9 0.5 0.3 Wheat 0.7
5.3 WHO Cluster diet F  2.3 0.9 0.2 Wheat 1.4
5.2 ES adult 2.6 0.8 0.3 Peppers 1.0
4.9 PT General population 3.0 0.4 0.3 Peppers 1.3
4.1 FR all population 1.4 0.5 0.3 Tea (dried leaves and stalks,  1.0
4.1 NL general 1.4 0.8 0.3 Strawberries  1.2
3.9 FI  adult 1.4 1.0 0.3 Cucumbers 0.7
3.9 PL  general population 2.9 0.2 0.1 Apples 0.6
3.7 DK adult 1.4 0.6 0.3 Cucumbers 0.8
3.5 LT adult 2.1 0.4 0.2 Potatoes 0.8 Tomatoes Cucumbers
Tea (dried leaves and stalks, 
Beans (with pods)
Beans (with pods)
Tea (dried leaves and stalks, 
Potatoes
Tea (dried leaves and stalks, 
Milk and cream, 
Tea (dried leaves and stalks, 
Beans (with pods)
Tea (dried leaves and stalks, 
Beans (with pods)
Beans (with pods)
Tomatoes
Cucumbers
Strawberries 
Tea (dried leaves and stalks, 
Tea (dried leaves and stalks, 
Tomatoes
Tomatoes
Tea (dried leaves and stalks, 
Strawberries 
Tomatoes
Tomatoes
Potatoes
Tomatoes
Tea (dried leaves and stalks, 
Tomatoes
Beans (with pods)
Tea (dried leaves and stalks, 
Tomatoes
Tomatoes
Strawberries 
Beans (with pods)
Spiromesifen
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment
The risk assessment for tea is performed for a risk assessment residue definition "the sum of spiromesifen and spiromesifen-enol, expressed as spiromesifen".
Commodity / 
group of commodities
Commodity / 
group of commodities
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Spiromesifen is unlikely to present a public health concern.
Beans (with pods)
Tomatoes
Tomatoes
Tomatoes
Tea (dried leaves and stalks, 
Tomatoes
Wheat
Tomatoes
Tomatoes
Tomatoes
Tomatoes
Conclusion:
Tomatoes
Tomatoes
Tomatoes
Tomatoes
Tea (dried leaves and stalks, 
Tomatoes
Tomatoes
Tomatoes
Prepare workbook for refined 
calculations
Undo refined calculationsModification of the existing MRL for spiromesifen in tea 
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Acute risk assessment /children - refined calculations Acute risk assessment / adults / general population - refined calculations
The acute risk assessment is based on the ARfD.
--- --- --- ---
IESTI 1 *) **) IESTI 2 *) **) IESTI 1 *) **) IESTI 2 *) **)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
0.9 Tea  20.4 / - 0.9 Tea  20.4 / - 0.3 Tea  20.4 / - 0.3 Tea  20.4 / -
No of critical MRLs (IESTI 1) --- No of critical MRLs (IESTI 2) ---
--- ---
***) ***)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
No of commodities for which 
ARfD/ADI is exceeded:
No of commodities for which 
ARfD/ADI is exceeded (IESTI 1):
Conclusion:
For Spiromesifen IESTI 1 and IESTI 2 were calculated for food commodities for which pTMRLs were submitted and for which consumption data are available.
In the IESTI 1 calculation, the variability factors were 10, 7 or 5 (according to JMPR manual 2002), for lettuce a variability factor of 5 was used. 
In the IESTI 2 calculations, the variability factors of 10 and 7 were replaced by 5. For lettuce the calculation was performed with a variabilty factor of 3.  
No of commodities for which ARfD/ADI is 
exceeded (IESTI 2):
For each commodity the calculation is based on the highest reported MS consumption per kg bw and the corresponding unit weight from the MS with the critical consumption. If no data on the unit weight was available from that MS an average 
European unit weight was used for the IESTI calculation. 
No of commodities for which ARfD/ADI 
is exceeded:
Threshold MRL is the  calculated residue level which would leads to an exposure equivalent to 100 % of the ARfD.  
No of commodities for which ARfD/ADI 
is exceeded (IESTI 1):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 2):
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*) The results of the IESTI calculations are reported for at least 5 commodities. If the ARfD is exceeded for more than 5 commodities, all IESTI values > 90% of ARfD are reported. 
**) pTMRL: provisional temporary MRL
***) pTMRL: provisional temporary MRL for unprocessed commodity
No exceedance of the ARfD/ADI was identified for any unprocessed commodity. 
For processed commodities, no exceedance of the ARfD/ADI was identified.
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C.  EXISTING EU MAXIMUM RESIDUE LEVELS (MRLS) 
(Pesticides – Web Version – EU MRLs (File created on 23/11/2012 11:28)) 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
100000  1. FRUIT FRESH OR 
FROZEN; NUTS 
  
110000  (i) Citrus fruit  0,02* 
110010  Grapefruit (Shaddocks, 
pomelos, sweeties, tangelo, 
ugli and other hybrids) 
0,02* 
110020  Oranges (Bergamot, bitter 
orange, chinotto and other 
hybrids) 
0,02* 
110030  Lemons (Citron, lemon )  0,02* 
110040  Limes  0,02* 
110050  Mandarins (Clementine, 
tangerine and other hybrids) 
0,02* 
110990  Others  0,02* 
120000  (ii) Tree nuts (shelled or 
unshelled) 
0,02* 
120010  Almonds  0,02* 
120020  Brazil nuts  0,02* 
120030  Cashew nuts  0,02* 
120040  Chestnuts  0,02* 
120050  Coconuts  0,02* 
120060  Hazelnuts (Filbert)  0,02* 
120070  Macadamia  0,02* 
120080  Pecans  0,02* 
120090  Pine nuts  0,02* 
120100  Pistachios  0,02* 
120110  Walnuts  0,02* 
120990  Others  0,02* 
130000  (iii) Pome fruit  0,02* 
130010  Apples (Crab apple)  0,02* 
130020  Pears (Oriental pear)  0,02* 
130030  Quinces  0,02* 
130040  Medlar  0,02* 
130050  Loquat  0,02* 
130990  Others  0,02* 
140000  (iv) Stone fruit  0,02* 
140010  Apricots  0,02* 
140020  Cherries (sweet cherries, sour 
cherries) 
0,02* 
140030  Peaches (Nectarines and 
similar hybrids) 
0,02* 
140040  Plums (Damson, greengage, 
22rench22ra) 
0,02* 
140990  Others  0,02* 
150000  (v) Berries & small fruit    
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
151000  (a) Table and wine grapes  0,02* 
151010  Table grapes  0,02* 
151020  Wine grapes  0,02* 
152000  (b) Strawberries  1 
153000  © Cane fruit  0,02* 
153010  Blackberries  0,02* 
153020  Dewberries (Loganberries, 
Boysenberries, and 
cloudberries) 
0,02* 
153030  Raspberries (Wineberries )  0,02* 
153990  Others  0,02* 
154000  (d) Other small fruit & berries  0,02* 
154010  Blueberries (Bilberries 
cowberries (red bilberries)) 
0,02* 
154020  Cranberries  0,02* 
154030  Currants (red, black and white)  0,02* 
154040  Gooseberries (Including 
hybrids with other ribes 
species) 
0,02* 
154050  Rose hips  0,02* 
154060  Mulberries (arbutus berry)  0,02* 
154070  Azarole (22rench22ranean 
medlar) 
0,02* 
154080  Elderberries (Black 
chokeberry (appleberry), 
mountain ash, azarole, 
buckthorn (sea sallowthorn), 
hawthorn, service berries, and 
other treeberries) 
0,02* 
154990  Others  0,02* 
160000  (vi) Miscellaneous fruit    
161000  (a) Edible peel  0,02* 
161010  Dates  0,02* 
161020  Figs  0,02* 
161030  Table olives  0,02* 
161040  Kumquats (Marumi 
kumquats, nagami kumquats) 
0,02* 
161050  Carambola (Bilimbi)  0,02* 
161060  Persimmon  0,02* 
161070  Jambolan (java plum) (Java 
apple (water apple), pomerac, 
rose apple, Brazilean cherry 
(grumichama), Surinam 
cherry) 
0,02* 
161990  Others  0,02* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
162000  (b) Inedible peel, small    
162010  Kiwi  0,02* 
162020  Lychee (Litchi) (Pulasan, 
rambutan (hairy litchi)) 
0,02* 
162030  Passion fruit  1 
162040  Prickly pear (cactus fruit)  0,02* 
162050  Star apple  0,02* 
162060  American persimmon 
(Virginia kaki) (Black sapote, 
white sapote, green sapote, 
canistel (yellow sapote), and 
mammey sapote) 
0,02* 
162990  Others  0,02* 
163000  © Inedible peel, large    
163010  Avocados  0,02* 
163020  Bananas (Dwarf banana, 
plantain, apple banana) 
0,02* 
163030  Mangoes  0,02* 
163040  Papaya  1 
163050  Pomegranate  0,02* 
163060  Cherimoya (Custard apple, 
sugar apple (sweetsop) , llama 
and other medium sized 
Annonaceae) 
0,02* 
163070  Guava  0,02* 
163080  Pineapples  0,02* 
163090  Bread fruit (Jackfruit)  0,02* 
163100  Durian  0,02* 
163110  Soursop (guanabana)  0,02* 
163990  Others  0,02* 
200000  2. VEGETABLES FRESH 
OR FROZEN 
  
210000  (i) Root and tuber vegetables  0,02* 
211000  (a) Potatoes  0,02* 
212000  (b) Tropical root and tuber 
vegetables 
0,02* 
212010  Cassava (Dasheen, eddoe 
(Japanese taro), tannia) 
0,02* 
212020  Sweet potatoes  0,02* 
212030  Yams (Potato bean (yam 
bean), Mexican yam bean) 
0,02* 
212040  Arrowroot  0,02* 
212990  Others  0,02* 
213000  © Other root and tuber 
vegetables except sugar beet 
0,02* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
213010  Beetroot  0,02* 
213020  Carrots  0,02* 
213030  Celeriac  0,02* 
213040  Horseradish  0,02* 
213050  Jerusalem artichokes  0,02* 
213060  Parsnips  0,02* 
213070  Parsley root  0,02* 
213080  Radishes (Black radish, 
Japanese radish, small radish 
and similar varieties) 
0,02* 
213090  Salsify (Scorzonera, Spanish 
salsify (Spanish oysterplant)) 
0,02* 
213100  Swedes  0,02* 
213110  Turnips  0,02* 
213990  Others  0,02* 
220000  (ii) Bulb vegetables  0,02* 
220010  Garlic  0,02* 
220020  Onions (Silverskin onions)  0,02* 
220030  Shallots  0,02* 
220040  Spring onions (Welsh onion 
and similar varieties) 
0,02* 
220990  Others  0,02* 
230000  (iii) Fruiting vegetables    
231000  (a) Solanacea    
231010  Tomatoes (Cherry tomatoes, )  1 
231020  Peppers (Chilli peppers)  0,5 
231030  Aubergines (egg plants) 
(Pepino) 
0,5 
231040  Okra, lady’s fingers  0,02* 
231990  Others  0,02* 
232000  (b) Cucurbits – edible peel    
232010  Cucumbers  0,3 
232020  Gherkins  0,3 
232030  Courgettes (Summer squash, 
marrow (patisson)) 
0,3 
232990  Others  0,02* 
233000  © Cucurbits-inedible peel  0,3 
233010  Melons (Kiwano )  0,3 
233020  Pumpkins (Winter squash)  0,3 
233030  Watermelons  0,3 
233990  Others  0,3 
234000  (d) Sweet corn  0,02* 
239000  (e) Other fruiting vegetables  0,02* 
240000  (iv) Brassica vegetables  0,02* 
241000  (a) Flowering brassica  0,02* Modification of the existing MRL for spiromesifen in tea 
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Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
241010  Broccoli (Calabrese, Chinese 
broccoli, Broccoli raab) 
0,02* 
241020  Cauliflower  0,02* 
241990  Others  0,02* 
242000  (b) Head brassica  0,02* 
242010  Brussels sprouts  0,02* 
242020  Head cabbage (Pointed head 
cabbage, red cabbage, savoy 
cabbage, white cabbage) 
0,02* 
242990  Others  0,02* 
243000  © Leafy brassica  0,02* 
243010  Chinese cabbage (Indian 
(Chinese) mustard, pak choi, 
Chinese flat cabbage (tai goo 
choi), peking cabbage (pe-
tsai), cow cabbage) 
0,02* 
243020  Kale (Borecole (curly kale), 
collards) 
0,02* 
243990  Others  0,02* 
244000  (d) Kohlrabi  0,02* 
250000  (v) Leaf vegetables & fresh 
herbs 
0,02* 
251000  (a) Lettuce and other salad 
plants including Brassicacea 
0,02* 
251010  Lamb´s lettuce (Italian 
cornsalad) 
0,02* 
251020  Lettuce (Head lettuce, lollo 
rosso (cutting lettuce), iceberg 
lettuce, romaine (cos) lettuce) 
0,02* 
251030  Scarole (broad-leaf endive) 
(Wild chicory, red-leaved 
chicory, radicchio, curld leave 
endive, sugar loaf) 
0,02* 
251040  Cress  0,02* 
251050  Land cress  0,02* 
251060  Rocket, Rucola (Wild rocket)  0,02* 
251070  Red mustard  0,02* 
251080  Leaves and sprouts of Brassica 
spp (Mizuna) 
0,02* 
251990  Others  0,02* 
252000  (b) Spinach & similar (leaves)  0,02* 
252010  Spinach (New Zealand 
spinach, turnip greens (turnip 
tops)) 
0,02* 
252020  Purslane (Winter purslane 
(miner’s lettuce), garden 
purslane, common purslane, 
sorrel, glassworth) 
0,02* 
252030  Beet leaves (chard) (Leaves of 
beetroot) 
0,02* 
252990  Others  0,02* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
253000  © Vine leaves (grape leaves)  0,02* 
254000  (d) Water cress  0,02* 
255000  (e) Witloof  0,02* 
256000  (f) Herbs  0,02* 
256010  Chervil  0,02* 
256020  Chives  0,02* 
256030  Celery leaves (fennel leaves , 
Coriander leaves, dill leaves, 
Caraway leaves, lovage, 
angelica, sweet cisely and 
other Apiacea) 
0,02* 
256040  Parsley  0,02* 
256050  Sage (Winter savory, summer 
savory, ) 
0,02* 
256060  Rosemary  0,02* 
256070  Thyme ( marjoram, oregano)  0,02* 
256080  Basil (Balm leaves, mint, 
peppermint) 
0,02* 
256090  Bay leaves (laurel)  0,02* 
256100  Tarragon (Hyssop)  0,02* 
256990  Others  0,02* 
260000  (vi) Legume vegetables (fresh)    
260010  Beans (with pods) (Green 
bean (23rench beans, snap 
beans), scarlet runner bean, 
slicing bean, yardlong beans) 
1 
260020  Beans (without pods) (Broad 
beans, Flageolets, jack bean, 
lima bean, cowpea) 
0,02* 
260030  Peas (with pods) (Mangetout 
(sugar peas)) 
0,02* 
260040  Peas (without pods) (Garden 
pea, green pea, chickpea) 
0,02* 
260050  Lentils  0,02* 
260990  Others  0,02* 
270000  (vii) Stem vegetables (fresh)  0,02* 
270010  Asparagus  0,02* 
270020  Cardoons  0,02* 
270030  Celery  0,02* 
270040  Fennel  0,02* 
270050  Globe artichokes  0,02* 
270060  Leek  0,02* 
270070  Rhubarb  0,02* 
270080  Bamboo shoots  0,02* 
270090  Palm hearts  0,02* 
270990  Others  0,02* 
280000  (viii) Fungi  0,02* 
280010  Cultivated (Common 
mushroom, Oyster 
mushroom, Shi-take) 
0,02* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
280020  Wild (Chanterelle, Truffle, 
Morel ,) 
0,02* 
280990  Others  0,02* 
290000  (ix) Sea weeds  0,02* 
300000  3. PULSES, DRY  0,02* 
300010  Beans (Broad beans, navy 
beans, flageolets, jack beans, 
lima beans, field beans, 
cowpeas) 
0,02* 
300020  Lentils  0,02* 
300030  Peas (Chickpeas, field peas, 
chickling vetch) 
0,02* 
300040  Lupins  0,02* 
300990  Others  0,02* 
400000  4. OILSEEDS AND 
OILFRUITS 
0,02* 
401000  (i) Oilseeds  0,02* 
401010  Linseed  0,02* 
401020  Peanuts  0,02* 
401030  Poppy seed  0,02* 
401040  Sesame seed  0,02* 
401050  Sunflower seed  0,02* 
401060  Rape seed (Bird rapeseed, 
turnip rape) 
0,02* 
401070  Soya bean  0,02* 
401080  Mustard seed  0,02* 
401090  Cotton seed  0,02* 
401100  Pumpkin seeds  0,02* 
401110  Safflower  0,02* 
401120  Borage  0,02* 
401130  Gold of pleasure  0,02* 
401140  Hempseed  0,02* 
401150  Castor bean  0,02* 
401990  Others  0,02* 
402000  (ii) Oilfruits  0,02* 
402010  Olives for oil production  0,02* 
402020  Palm nuts (palmoil kernels)  0,02* 
402030  Palmfruit  0,02* 
402040  Kapok  0,02* 
402990  Others  0,02* 
500000  5. CEREALS  0,02* 
500010  Barley  0,02* 
500020  Buckwheat  0,02* 
500030  Maize  0,02* 
500040  Millet (Foxtail millet, teff)  0,02* 
500050  Oats  0,02* 
500060  Rice  0,02* 
500070  Rye  0,02* 
500080  Sorghum  0,02* 
500090  Wheat (Spelt Triticale)  0,02* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
500990  Others  0,02* 
600000  6. TEA, COFFEE, HERBAL 
INFUSIONS AND COCOA 
0,02* 
610000  (i) Tea (dried leaves and stalks, 
fermented or otherwise of 
Camellia sinensis) 
0,02* 
620000  (ii) Coffee beans  0,02* 
630000  (iii) Herbal infusions (dried)  0,02* 
631000  (a) Flowers  0,02* 
631010  Camomille flowers  0,02* 
631020  Hybiscus flowers  0,02* 
631030  Rose petals  0,02* 
631040  Jasmine flowers  0,02* 
631050  Lime (linden)  0,02* 
631990  Others  0,02* 
632000  (b) Leaves  0,02* 
632010  Strawberry leaves  0,02* 
632020  Rooibos leaves  0,02* 
632030  Maté  0,02* 
632990  Others  0,02* 
633000  © Roots  0,02* 
633010  Valerian root  0,02* 
633020  Ginseng root  0,02* 
633990  Others  0,02* 
639000  (d) Other herbal infusions  0,02* 
640000  (iv) Cocoa (fermented beans)  0,02* 
650000  (v) Carob (st johns bread)  0,02* 
700000  7. HOPS (dried) , including 
hop pellets and unconcentrated 
powder 
0,02* 
800000  8. SPICES    
810000  (i) Seeds  0,02* 
810010  Anise  0,02* 
810020  Black caraway  0,02* 
810030  Celery seed (Lovage seed)  0,02* 
810040  Coriander seed  0,02* 
810050  Cumin seed  0,02* 
810060  Dill seed  0,02* 
810070  Fennel seed  0,02* 
810080  Fenugreek  0,02* 
810090  Nutmeg  0,02* 
810990  Others  0,02* 
820000  (ii) Fruits and berries    
820010  Allspice  0,02* 
820020  Anise pepper (Japan pepper)  0,02* 
820030  Caraway  0,02* 
820040  Cardamom  0,02* 
820050  Juniper berries  0,02* 
820060  Pepper, black and white (Long 
pepper, pink pepper) 
0,02* Modification of the existing MRL for spiromesifen in tea 
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Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
820070  Vanilla pods  0,02* 
820080  Tamarind  0,02* 
820990  Others  0,05 
830000  (iii) Bark  0,02* 
830010  Cinnamon (Cassia )  0,02* 
830990  Others  0,02* 
840000  (iv) Roots or rhizome  0,02* 
840010  Liquorice  0,02* 
840020  Ginger  0,02* 
840030  Turmeric (Curcuma)  0,02* 
840040  Horseradish  0,02* 
840990  Others  0,02* 
850000  (v) Buds  0,02* 
850010  Cloves  0,02* 
850020  Capers  0,02* 
850990  Others  0,02* 
860000  (vi) Flower stigma  0,02* 
860010  Saffron  0,02* 
860990  Others  0,02* 
870000  (vii) Aril  0,02* 
870010  Mace  0,02* 
870990  Others  0,02* 
900000  9. SUGAR PLANTS  0,02* 
900010  Sugar beet (root)  0,02* 
900020  Sugar cane  0,02* 
900030  Chicory roots  0,02* 
900990  Others  0,02* 
1000000  10. PRODUCTS OF 
ANIMAL ORIGIN-
TERRESTRIAL ANIMALS 
0,01* 
1010000  (i) Meat, preparations of meat,  0,01* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
offals, blood, animal fats fresh 
chilled or frozen, salted, in 
brine, dried or smoked or 
processed as flours or meals 
other processed products such 
as sausages and food 
preparations based on these 
1011000  (a) Swine  0,01* 
1011010  Meat  0,01* 
1011020  Fat free of lean meat  0,01* 
1011030  Liver  0,01* 
1011040  Kidney  0,01* 
1011050  Edible offal  0,01* 
1011990  Others  0,01* 
1012000  (b) Bovine  0,01* 
1012010  Meat  0,01* 
1012020  Fat  0,01* 
1012030  Liver  0,01* 
1012040  Kidney  0,01* 
1012050  Edible offal  0,01* 
1012990  Others  0,01* 
1013000  © Sheep  0,01* 
1013010  Meat  0,01* 
1013020  Fat  0,01* 
1013030  Liver  0,01* 
1013040  Kidney  0,01* 
1013050  Edible offal  0,01* 
1013990  Others  0,01* 
1014000  (d) Goat  0,01* 
1014010  Meat  0,01* 
1014020  Fat  0,01* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
1014030  Liver  0,01* 
1014040  Kidney  0,01* 
1014050  Edible offal  0,01* 
1014990  Others  0,01* 
1015000  (e) Horses, asses, mules or 
hinnies 
0,01* 
1015010  Meat  0,01* 
1015020  Fat  0,01* 
1015030  Liver  0,01* 
1015040  Kidney  0,01* 
1015050  Edible offal  0,01* 
1015990  Others  0,01* 
1016000  (f) Poultry –chicken, geese, 
duck, turkey and Guinea fowl-
, ostrich, pigeon 
0,01* 
1016010  Meat  0,01* 
1016020  Fat  0,01* 
1016030  Liver  0,01* 
1016040  Kidney  0,01* 
1016050  Edible offal  0,01* 
1016990  Others  0,01* 
1017000  (g) Other farm animals 
(Rabbit, Kangaroo) 
0,01* 
1017010  Meat  0,01* 
1017020  Fat  0,01* 
1017030  Liver  0,01* 
1017040  Kidney  0,01* 
1017050  Edible offal  0,01* 
1017990  Others  0,01* 
1020000  (ii) Milk and cream, not 
concentrated, nor containing 
0,01* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply 
Spiromesifen 
added sugar or sweetening 
matter, butter and other fats 
derived from milk, cheese and 
curd 
1020010  Cattle  0,01* 
1020020  Sheep  0,01* 
1020030  Goat  0,01* 
1020040  Horse  0,01* 
1020990  Others  0,01* 
1030000  (iii) Birds’ eggs, fresh 
preserved or cooked Shelled 
eggs and egg yolks fresh, 
dried, cooked by steaming or 
boiling in water, moulded, 
frozen or otherwise preserved 
whether or not containing 
added sugar or sweetening 
matter 
0,01* 
1030010  Chicken  0,01* 
1030020  Duck  0,01* 
1030030  Goose  0,01* 
1030040  Quail  0,01* 
1030990  Others  0,01* 
1040000  (iv) Honey (Royal jelly, 
pollen) 
0,01* 
1050000  (v) Amphibians and reptiles 
(Frog legs, crocodiles) 
0,01* 
1060000  (vi) Snails  0,01* 
1070000  (vii) Other terrestrial animal 
products 
0,01* 
(*)  Indicates  lower  limit  of  analytical 
determination 
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D.  LIST OF METABOLITES AND RELATED STRUCTURAL FORMULA  
Common name  IUPAC name  Structure 
Spiromesifen-enol (M01)  - 
O
C H3
CH3
CH3
OH
O
 
4-hydroxymethyl-
spiromesifen-enol (M02) 
- 
O CH3
CH3
OH
O
O H
 
4-hydroxymethyl-
glucoside-  spiromesifen-
enol (M03) 
- 
O CH3
CH3
OH
O
O
Glucose  
Dihydroxy-  spiromesifen-
enol (M04) 
- 
O
C H3
CH3
CH3
OH
O
 
OH
 
 2 
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ABBREVIATIONS 
ADI  acceptable daily intake 
ArfD  acute reference dose 
a.s.  active substance 
BBCH  growth stages of mono- and dicotyledonous plants 
bw  body weight 
CF  conversion  factor  for  enforcement  residue  definition  to  risk  assessment 
residue definition 
CoA  co-enzyme A 
CXL  Codex Maximum Residue Limit (Codex MRL) 
d  day 
DAR  Draft Assessment Report  
DAT  days after treatment 
EC  European Community  
EFSA  European Food Safety Authority 
EMS  evaluating Member State 
eq  residue expressed as a.s. equivalent 
EU  European Union 
GAP  good agricultural practice 
GCPF  Global Crop Protection Federation (former GIFAP) 
GLP  Good Laboratory Practice 
ha  hectare 
hL  hectolitre 
HPLC  high performance liquid chromatography 
IE   Ireland 
ISO  International Organisation for Standardisation 
IUPAC  International Union of Pure and Applied Chemistry 
kg  kilogram 
L  litre 
LOQ  limit of quantification  
MRL  maximum residue level  
MS/MS  tandem mass spectrometry  
MW  molecular weight 
OECD  Organisation for Economic Co-operation and Development 
PF  processing factor 
PHI  pre-harvest interval Modification of the existing MRL for spiromesifen in tea 
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PRIMo  (EFSA) Pesticide Residues Intake Model 
Rber  statistical calculation of the MRL by using a non-parametric method 
Rmax  statistical calculation of the MRL by using a parametric method 
RD  residue definition 
RMS  rapporteur Member State 
SC  suspension concentrate 
TRR  total radioactive residue 
WHO  World Health Organization 
 
 
 